NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

与COVID-19相关的临床试验,远程医疗,疫苗和其他市场(修订版)

COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

出版商 Kalorama Information 商品编码 984999
出版日期 内容资讯 英文
商品交期: 最快1-2个工作天内
价格
与COVID-19相关的临床试验,远程医疗,疫苗和其他市场(修订版) COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets
出版日期: 2020年11月02日内容资讯: 英文
简介

本报告研究了与COVID-19相关的临床试验,远程医疗,疫苗和其他市场的最新信息,包括市场概况,分子诊断/抗原和抗体检测/疫苗的市场变化等。我们提供以下信息:类型和地区。

目录

第1章执行摘要

  • 概述
    • COVID-19总计
    • 主要国家/地区:每7天平均COVID病例数变化(每百万人)
    • COVID-19测试
  • 范围和方法调查方法

第2章COVD-19诊断

  • 临床检查状况
    • 众多批准
  • FDA批准的检查
    • 分子
    • 免疫学检查
  • 改变情况的COVID-19抗原检测测试
    • COVID-19市场
  • COVID-19测试开发
    • COVID-19,影响了LDT市场
    • 紧急医疗中心和COVID-19测试
    • 各种SARS-CoV-2抗体试剂盒的准确性
    • 在COVID-19 "Nudge" 测试的临床研究中很有希望
    • 高度敏感的基于CRISPR的新COVID-19测试等
  • 产品开发
    • NIH,BARDA:根据COVID-19合同获得9835万美元
    • 新的COVIDNGS检查
    • 提示:为COVID-19测试获得DOD资助
    • Beckman Coulter:COVID-19 IgM分析
    • GenMark:多重测试等。
  • 新法规
    • 对于COVID-19测试重要的LDT由AACC

第3章远程医疗

  • COVID-19对远程医疗的影响
    • COVID-19的要点
    • RPM/远程医疗市场表现
  • 企业绩效
    • ABBOTT
    • AMERICAN WELL (AMWELL)
    • ASCOM HOLDING AG
    • BRIGHT.MD
    • DOCTOR ON DEMAND
    • EKO DEVICES
    • G MEDICAL INNOVATIONS HOLDING LTD.
    • GENERAL DEVICES
    • GLOOKO
    • MASIMO
    • MEDTRONIC
    • OSI SYSTEMS
    • PHILIPS - KONINKLIJKE PHILIPS N.V. (ROYAL PHILIPS)
    • TELADOC HEALTH
    • THINKLABS
    • TYTOCARE

第4章COVID-19和生命科学调查

  • 关闭调查室并否认身份
  • COVID-19调查和出版物
  • COVID-19用于治疗开发的研究抗体
  • 生命科学工具市场注意事项

第5章疫苗

  • 美国成年人如何接受COVID-19疫苗
  • 通用冠状病毒疫苗?
    • Moderna:来自中东/非洲的批准并提交营销批准
目录
Product Code: 20-036

COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic.

Particular sections address the most important market changes:

  • Molecular Diagnostics: COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
  • Antigen and Antibody Tests: Never have immunoassays been of such worldwide attention, as antibody tests are greatly sought. With this, come concerns about accuracy levels on broad populations and greater knowledge about development times. There are now immunoassays in development. We track these efforts and provide commentary on the role of these tests in a threat so far dominated by molecular diagnostics.
  • Vaccines: We look at the vaccines in development and the struggles with vaccine discovery and manufacturing in other pandemics.
  • Life Science Research - what are the trends in experiments and publications, how has COVID-19 affected lab research volume and tools markets.
  • Remote Patient Monitoring: Already a healthcare trend that was catching on but perhaps struggling to convince payors of its critical necessity, remote patient monitoring and telehealth transformed overnight with social distancing policies and relaxed HIPAA rules. Kalorama has contacted a number of companies for October 2020 updates.

As part of this report's offerings, the following information is included:

  • Market for COVID-19 by Type: PCR, Antigen, Antibody
  • Market for COVID-19 by Region: US, Europe, Asia, ROW
  • Current EUA Test Approvals
  • Antigen COVID-19 Tests
  • Overall Clinical Lab Volume Trends (April to September)
  • Market for Telehealth and COVID-19 Impact
  • Telehealth Company Responses to COVID-19
  • COVID-19 Vaccines in Development
  • COVID-19 Vaccine Pre Sales

This report does not seek to provide a data-driven market assessment due to the rapidly-changing situation, but does provide analyst commentary that may assist customers needing to work out models. Some of Kalorama Information's market estimates provide foundational bases on which to judge potential market impact.

Commentary and analysis from Kalorama authors who have studied markets in some cases for decades add understanding to the current, often chaotic, market atmosphere. Further publications and surveys from Kalorama Information will provide additional market impact data.

Companies Discussed Include:

  • Abbott
  • American Well (Amwell)
  • Ascom Holding
  • Astra Zeneca
  • Beckman Coulter
  • Becton Dickinson
  • Bright.Md
  • Cepheid
  • Cue Health
  • Doctor On Demand
  • Eko Devices
  • Eurofins
  • G Medical Innovations Holding Ltd.
  • General Devices
  • Genmark
  • Hologic
  • Johnson and Johnson
  • Medtronic
  • Moderna
  • Philips
  • Qiagen
  • Quidel
  • Roche
  • Teladoc Health

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • OVERVIEW
    • COVID-19 Cases Total
    • COVID Cases Rolling 7-Day Average Per Million by Major Countries
    • COVID-19 TESTING
  • SCOPE AND METHODOLOGY

CHAPTER 2: COVD-19 DIAGNOSTICS

  • CLINICAL LAB SITUATION
    • Table: Clinical Labs Percent of Labs Experiencing Volume Declines Due to COVID-19 and Shutdowns [Major, Minor, No Decline]
    • Large Number of Approvals
  • TEST APPROVED BY FDA
    • Molecular
    • Immunoassays
      • Table: Tests for COVID-19 Authorized by FDA
  • ANTIGENT TESTS CHANGE COVID-19 LANDSCAPE
    • COVID-19 MARKET
      • Figure : IVD COVID-19 Market, Distribution by Region (North America, Europe, Asia Pacific, RoW), 2020 % KOREAN COVID-19 TESTING FOCUS
  • COVID-19 TESTING DEVELOPMENTS
    • COVID Driving LDT Market
    • CMS Seeks to Spur Speed of Results by Cutting Fees for Slower Labs
    • Urgent care Centers and COVID-19 testing
    • Study finds SARS-CoV-2 antibody kits have varying accuracy
    • COVID-19 "Nudge" Test shows promise in clinical study
    • New CRISPR-based COVID-19 test shows high sensitivity
    • Blood test score helps predict COVID-19 severity
    • Biomarkers to determine COVID-19 odds: GW researchers
  • PRODUCT DEVELOPMENTS
    • NIH, BARDA award $98.35M in COVID-19 Contracts
    • New COVID NGS Test
    • Cue secures DOD Grant for COVID-19 tests
    • Beckman Coulter COVID-19 IgM assay
    • GenMark Multiplex test
    • 20/20 takes orders for 1st POC Fingerstick COVID-19 test
    • Quidel gets EUA for Combo flu, COVID-19 test
    • Biocept reaches COVID-19 testing milestone
    • LabCorp nabs EUA for new COVID-19 molecular test
    • FDA issues EUA for OralDNA's oral rinse COVID-19 test
    • LDTs AND COVID-19
  • NEW LEGISLATION
    • LDTs Critical for COVID-19 Testing, Says AACC

CHAPTER 3: TELEHEALTH

  • COVID-19 IMPACT ON TELEHALTH: KEY TAKEAWAYS
    • COVID-19 Key Takeaways
    • RPM/Telehealth Market Performance
  • COMPANY RESULTS
    • ABBOTT
    • AMERICAN WELL (AMWELL)
    • ASCOM HOLDING AG
    • BRIGHT.MD
    • DOCTOR ON DEMAND
    • EKO DEVICES
    • G MEDICAL INNOVATIONS HOLDING LTD.
    • GENERAL DEVICES
    • GLOOKO
    • MASIMO
    • MEDTRONIC
    • OSI SYSTEMS
    • PHILIPS - KONINKLIJKE PHILIPS N.V. (ROYAL PHILIPS)
    • TELADOC HEALTH
    • THINKLABS
    • TYTOCARE

CHAPTER 4. COVID-19 AND LIFE SCIENCE RESEARCH

  • RESEARCH LAB SHUTDOWN AND DECLINE STATUS
  • COVID-19 RESEARCH AND PUBLICATIONS
  • SHINING A SPOTLIGHT IN A CHALLENGED MARKET: RESEARCH ANTIBODIES FOR COVID-19 THERAPEUTIC DEVELOPMENT
  • LIFE SCIENCE TOOLS MARKET CONSIDERATIONS

CHAPTER 5. VACCINES

  • Figure: COVID-19 Per Capita Doses Ordered by Country
  • Figure: COVID-19 Vaccine Candidates: Government Presales
  • HOW WILLING ARE U.S. ADULTS TO ACCEPT A COVID-19 VACCINE?
  • UNIVERSAL CORONAVIRUS VACCINES?
    • Moderna gets nod from EMA to submit marketing authorization